Answers are grounded in this paper and cite their sources.
Background: Dysmenorrhea, dyspareunia and endometriosis-associated pain are considered the main complications in young women with endometriosis.Proscur capsule contains several traditional herbal medicines that have shown anti-inflammatory, antioxidant, anti-androgenic, anti-estrogenic, pelvic pain reducing and analgesic effects in previous pre-clinical and clinical studies.Objective: This study aimed to investigate the clinical efficacy and safety of a standardized polyherbal formulation (proscur) for endometriosis-associated pain in young women with endometriosis.Methods: This study was a single-center, randomized, double-blinded, placebo-controlled, clinical trial.A total of 90 patients aged 20-45 years with endometriosis-associated pain were enrolled.Participants were randomly assigned to the proscur or placebo groups in a ratio of 1:1 and efficacy evaluation was conducted at day 30, 60 and 90.The participants orally administered proscur or placebo two times a day for 12 weeks.The study outcomes were measured based on a change of visual analogue scale (VAS) score and the short form endometriosis health profile questionnaire (EHP-5).Results: We observed an increase in pain relief in women who receive proscur.The serum measures of CA-125 declined in those who received proscur.Intervention was well tolerated, and no serious adverse events occurred.Conclusions: Our study showed that proscur relieved endometriosis-associated pain and CA-125 level with minimal side-effects after treatment.Therefore, proscur combined with standard medical therapy could provide more clinical benefits for patients with endometriosis-associated pain.
No takes yet. Share an insight, caveat, or question.
Akhtari et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: